Skip to main content

Research Repository

Advanced Search

A randomised trial of the effect of the glycine reuptake inhibitor Org 25935 on cognitive performance in healthy male volunteers

Christmas, David; Diaper, Alison; Wilson, Sue; Rich, Ann; Phillips, Suzanne; Udo de Haes, Joanna; Sjogren, Magnus; Nutt, David

Authors

David Christmas

Sue Wilson

Ann Rich

Suzanne Phillips

Joanna Udo de Haes

Magnus Sjogren

David Nutt



Abstract

Objective Cognitive impairment is integral to many neurological illnesses. Specific enhancement of glutamatergic transmission may improve memory and learning. Org 25935 increases the synaptic availability of glycine, an obligate co-agonist with glutamate at N-methyl-d-aspartate receptors. We hypothesised that Org 25935 would acutely improve the learning and memory of healthy volunteers. Methods A randomised, double-blind, parallel-group, single-dose study of Org 25935 and placebo was carried out. Thirty-two healthy male volunteers took either 12-mg Org 25935 or matching placebo and were later assessed with the manikin task, digit span and verbal memory tests. Systematic assessments of cardiovascular and adverse events were also taken. Results There was no effect of Org 25935 on reaction time, number of correct responses or learning (greater or slower improvement over successive tasks) compared with placebo. Org 25935 caused significantly more dizziness and drowsiness compared with placebo; these side effects were mainly mild. Conclusions A single dose of Org 25935 does not improve learning or memory in healthy male individuals. However, the drug was well tolerated, and it remains to be seen whether it would have a positive effect on cognition in patient groups with pre-existing cognitive deficits. Copyright © 2014 John Wiley & Sons, Ltd. Copyright © 2014 John Wiley & Sons, Ltd.

Citation

Christmas, D., Diaper, A., Wilson, S., Rich, A., Phillips, S., Udo de Haes, J., …Nutt, D. (2014). A randomised trial of the effect of the glycine reuptake inhibitor Org 25935 on cognitive performance in healthy male volunteers. Human Psychopharmacology: Clinical and Experimental, 29(2), 163-171. https://doi.org/10.1002/hup.2384

Journal Article Type Article
Acceptance Date Jan 14, 2014
Online Publication Date Jan 14, 2014
Publication Date Mar 1, 2014
Deposit Date Nov 21, 2019
Journal Human Psychopharmacology
Print ISSN 0885-6222
Electronic ISSN 1099-1077
Publisher Wiley
Peer Reviewed Peer Reviewed
Volume 29
Issue 2
Pages 163-171
DOI https://doi.org/10.1002/hup.2384
Public URL https://uwe-repository.worktribe.com/output/4670083
Publisher URL https://doi.org/10.1002/hup.2384